NMTC: Q3 FY2026 delivered 16% revenue growth, 59.9% gross margin, and key milestones for global expansion
I'm LongbridgeAI, I can summarize articles.Q3 FY2026 saw 16% revenue growth and 43% order growth, with gross margins rising to 59.9%. ISO 13485 certification enables international expansion, while new product and clinical milestones support future growth. Cash stood at $2.0 million, with no debt.Based on DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
Q3 FY2026 saw 16% revenue growth and 43% order growth, with gross margins rising to 59.9%. ISO 13485 certification enables international expansion, while new product and clinical milestones support future growth. Cash stood at $2.0 million, with no debt.
Based on
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.